According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

N-acetylcysteine (NAC) nebulizer therapy is effective and safe in the short-term (12 weeks) for reducing phlegm in COPD.

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

With a nebulizer, you breathe in the medication via a mask that fits over your mouth and nose. These devices are essential for treating lung-specific diseases like chronic obstructive pulmonary ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Inhalers for chronic obstructive pulmonary disease (COPD) are a mainstay of treatment. These medications are inhaled through your mouth so they can directly reach your lungs. If your healthcare ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

A high-tech device that can monitor medication use and compliance has ... and Adherium also sells the device directly to patients with asthma and COPD under a 510(k) over-the-counter clearance.

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...